Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Business Wire-Archiv vom 10.12.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
10.12.23Incyte and Syndax Pharmaceuticals: Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease675Trial met its primary endpoint across all dose cohorts with 74% of patients at the 0.3 mg/kg dose achieving a complete or partial response within the first six months of treatment Data are featured...
► Artikel lesen
10.12.23Innate Pharma SA: Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023670Results confirm promising clinical activity, durable responses and favorable safety of lacutamab in heavily pretreated post-mogamulizumab Sézary Syndrome patients. Virtual KOL event will...
► Artikel lesen
10.12.23Belgian, Port Houston and Partners Sign Memorandum of Understanding on Energy Transition Cooperation469Today, H.E. Alexander De Croo, Prime Minister of Belgium, witnessed the signing of a Memorandum of Understanding on Energy Transition Cooperation between three Belgian and three Houston-based partners...
► Artikel lesen